A 6-week, randomized, open-label, comparative study to evaluate the efficacy and safety of rosuvastatin and atorvastatin in the treatment of hypercholesterolaemia in Hispanic subjects

Trial Profile

A 6-week, randomized, open-label, comparative study to evaluate the efficacy and safety of rosuvastatin and atorvastatin in the treatment of hypercholesterolaemia in Hispanic subjects

Completed
Phase of Trial: Phase III

Latest Information Update: 29 Apr 2008

At a glance

  • Drugs Atorvastatin; Rosuvastatin
  • Indications Hypercholesterolaemia
  • Focus Therapeutic Use
  • Acronyms STARSHIP
  • Sponsors AstraZeneca
  • Most Recent Events

    • 29 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top